Evidence map›Paper›PMID 21745713›Full record

ArticlePain2011

Engagement of descending inhibition from the rostral ventromedial medulla protects against chronic neuropathic pain.

Milena De Felice, Raul Sanoja, Ruizhong Wang, Louis Vera-Portocarrero, Janice Oyarzo, Tamara King, Michael H Ossipov, Todd W Vanderah, Josephine Lai, Gregory O Dussor and 3 more

Abstract readComparative Study
In one paragraph

Article in Pain, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 1 synthesis or guideline pooled it, 210 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Unveiling the Applications of Phytoconstituents in Neuropathic Pain.Central nervous system agents in medicinal chemistry · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Neuropathic pain; what we know and what we should do about it.Frontiers in pain research (Lausanne, Switzerland) · 2023
    Review
  18. Review
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Milena De FeliceDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724, USA Department of Pharmaceutical Sciences, University of British Columbia, 2146 East Mall, Vancouver, BC, Canada V6T 1Z4 Integrative Neuroscience Section, National Institute on Drug Abuse, National Institutes of Health, 251 Bayview Blvd, Baltimore, MD 21224, USA Medtronic Inc., Minneapolis, MN 55432, USA Ernest Gallo Clinic & Research Center, University of California, San Francisco, Emeryville, CA 94608, USA.
Raul Sanoja
Ruizhong Wang
Louis Vera-Portocarrero
Janice Oyarzo
Tamara King
Michael H Ossipov
Todd W Vanderah
Josephine Lai
Gregory O Dussor
Howard L Fields
Theodore J Price
Frank Porreca
University of Arizona · USErnest Gallo Clinic and Research Center · USMedtronic (United States) · USNational Institutes of Health · USUniversity of British Columbia · CA

Funding

Translation Control of Pain PlasticityR01NS065926 · NINDS · UNIVERSITY OF TEXAS DALLAS · PI PRICE, THEODORE J. · 2010 to 2023
$5.7M
Mechanisms of Spontaneous Neuropathic PainR01NS066958 · NINDS · UNIVERSITY OF ARIZONA · PI PORRECA, FRANK · 2010 to 2014
$1.6M
NINDS NIH HHS R01 NS065926NINDS NIH HHS R01NS065926NINDS NIH HHS R01 NS066958NINDS NIH HHS R01NS066958
6 · The paper itself

Abstract

A puzzling observation is why peripheral nerve injury results in chronic pain in some, but not all, patients. We explored potential mechanisms that may prevent the expression of chronic pain. Sprague Dawley (SD) or Holtzman (HZ) rats showed no differences in baseline sensory thresholds or responses to inflammatory stimuli. However, spinal nerve ligation (SNL)-induced tactile allodynia occurred in approximately 85% of SD and 50% of HZ rats, respectively. No apparent differences were observed in a survey of dorsal root ganglion or spinal neuropathic markers after SNL regardless of allodynic phenotype. SNL-induced allodynia was reversed by administration of lidocaine within the rostral ventromedial medulla (RVM), a site that integrates descending pain modulation via pain inhibitory (ie, OFF) and excitatory (ie, ON) cells. However, in SD or HZ rats with SNL but without allodynia, RVM lidocaine precipitated allodynia. Additionally, RVM lidocaine produced conditioned place preference in allodynic SD or HZ rats but conditioned place aversion in nonallodynic HZ rats. Similarly, RVM U69,593 (kappa opioid agonist) or blockade of spinal α(2) adrenergic receptors precipitated allodynia in previously nonallodynic HZ rats with SNL. All rats showed an equivalent first-phase formalin responses. However, HZ rats had reduced second-phase formalin behaviors along with fewer RVM OFF cell pauses and RVM ON cell bursts. Thus, expression of nerve injury-induced pain may ultimately depend on descending modulation. Engagement of descending inhibition protects in the transition from acute to chronic pain. These unexpected findings might provide a mechanistic explanation for medications that engage descending inhibition or mimic its consequences.

Indexed as

AnimalsChronic PainDisease Models, AnimalEfferent PathwaysMedulla OblongataNeuralgiaNeural InhibitionPain ThresholdRatsRats, Sprague-DawleySpinal Cord

Identifiers

PMID21745713
PMCPMC3222148
OpenAlexW2090068017

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.